Glycated hemoglobin, diabetes treatment and cancer risk in type 2 diabetes. A case-control study

Journal Title: Annals of Agricultural and Environmental Medicine - Year 2013, Vol 20, Issue 1

Abstract

Introduction: Type 2 diabetes is associated with an increased risk of some types of cancer. Diabetes treatment may also modify cancer risk.Objective: The aim of this retrospective, case-control study was to assess whether HbA[sub]1c[/sub] level and use of anti-diabetic drugs are associated with cancer development in a diabetic population.Materials and methods: The case group consisted of 53 patients who developed cancer after diagnosis of diabetes. They were compared with 53 diabetic subjects without cancer, strictly matched to a case group by age and gender. In both groups – apart from HbA1c and diabetes treatment – demographic data, smoking habits, comorbidities, BMI, diabetes duration, use of aspirin, antihypertensive and hypolipemic drugs were also analyzed.Results: Patients with cancer had a significantly higher mean HbA[sub]1c[/sub] value compared with the control group, 7.83±1.26% vs. 7.30±1.08%, respectively (p=0.022). The distribution of patients in four HbA1c categories (<7.0, 7.0-7.9, 8.0-8.9 and ≥9.0%) was significantly different between the two groups (p=0.031). The probability of cancer was higher among patients with HbA[sub]1c[/sub] value ≥8.0 % OR 3.160 (95% CI 1.342-7.440), p=0.013, and lower among patients using metformin, OR 0.228 (95% CI 0.083-0.633), p=0.006. The number of insulin users, insulin dose, duration of insulin treatment, and use of other anti-diabetic drugs were not significantly different between the two groups. Also, no significant differences were found between the two groups regarding other variables.Conclusions: The presented case-control study indicated an important role of metabolic control and confirmed the protective role of metformin in reducing cancer risk among patients with type 2 diabetes. Contrary to other studies, insulin use was not associated with a higher risk of cancer. Other anti-diabetic drugs appeared to have a neutral impact on cancer development.

Authors and Affiliations

Mariusz Dąbrowski

Keywords

Related Articles

An attempt to assess knowledge about tobacco dependence among students at the Medical University in Wroclaw

Introduction: Tobacco smoking is still one of the greatest, avoidable, singular causes of death. Although students of medical faculties are expected to have solid knowledge about smoking hazards, a significant number of...

???

Disorders of the musculoskeletal system among dentists from the aspect of ergonomics and prophylaxis.

The profession of dentist exposes them during their work to many burdensome and harmful factors. The irrational posture adopted by dentists during their work causes discomfort and disorders of the musculoskeletal system...

Reasons for delay in diagnosis and treatment of lung cancer among patients in Lublin Voivodeship who were consulted in Thoracic Surgery Department

Introduction: Despite the progress which has been made in the diagnosis and treatment of lung cancer, it is still one of the main causes of death in both men and women. The introduction of new therapeutic modalities did...

Replacement therapy of secondary hypothyroidism in children born with low body weight improves mental development

Background. Secondary hypothyroidism is observed in children after brain damage. The aim of the study was evaluation of the mental development in preterm-born children during replacement therapy with l-thyroxin because o...

Download PDF file
  • EP ID EP80589
  • DOI -
  • Views 135
  • Downloads 0

How To Cite

Mariusz Dąbrowski (2013). Glycated hemoglobin, diabetes treatment and cancer risk in type 2 diabetes. A case-control study. Annals of Agricultural and Environmental Medicine, 20(1), 116-121. https://www.europub.co.uk/articles/-A-80589